Blog
2 Wide-Moat Stocks That Are Drop-Dead Bargains Right Now
Cheap stocks aren't easy to find these days.
In the fourth year of the AI bull market, the S&P 500 now trades at a price-to-earnings ratio of 27, and according to the CAPE ratio, the index is as
Why AbbVie Stock Jumped Today
Shares of AbbVie (NYSE: ABBV) climbed on Monday after the pharmaceutical giant struck a deal to acquire clinical-stage biotech Apogee Therapeutics (NASDAQ: APGE) for $10.9 billion.
Image source
Could Investing $10,000 in SpaceX Make You a Millionaire?
Long-term investing can be an incredible path to wealth creation. For example, a $10,000 investment in Nvidia made just 10 years ago would now be worth roughly $1.84 million.
With Space Exploration
Is a Tesla-SpaceX Merger Imminent?
Space Exploration Technologies (NASDAQ: SPCX), better known as SpaceX, went public June 12, raising more than $85 billion from investors. Shares in the Elon Musk-founded company have since rallied
Why Netflix Stock Fell Today
Shares of Netflix (NASDAQ: NFLX) declined on Monday, as recent developments within the entertainment industry threaten to upend the competitive landscape.
Image source: The Motley Fool.
Back in
The Crowd Is Dumping SpaceX Stock. Here's Why I'd Be Buying It on the Dip.
Space Exploration Technologies (NASDAQ: SPCX) shares have only been trading on public markets for a few weeks. But the ride has already been extreme. After pricing its IPO at $135 per share, SpaceX
Why This Mid-Cap Biotech Could Be the Dark-Horse Threat to Eli Lilly and Novo Nordisk
The market for anti-obesity drugs seems to be at risk of calcifying into a dominant duopoly. Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO) split it through their GLP-1 medicines: Zepbound
What I Didn't Know About the ETF Liquidity Illusion
When I was first introduced to exchange-traded funds (ETFs), I was smitten. ETFs offer instant portfolio diversification, reduced market volatility risk, instant execution, attractive expense
Didn't Get Shares on SpaceX's IPO Day? Here's How Investors Can Increase Their Exposure.
The Space Exploration Technologies (NASDAQ: SPCX) IPO was one of the hottest events on the financial calendar this year. I haven't had so many friends and family tap me for investment advice since
A Little Good News for Tesla's Big Forgotten Product
With all the hype surrounding Tesla's (NASDAQ: TSLA) future ambitions that include humanoid robotics, driverless vehicles, and artificial intelligence, you can be forgiven for being sidetracked by
AbbVie's $10.9 Billion Apogee Deal Will Extend Its Immunology Dominance: Is It Time to Load Up on This Dividend King?
AbbVie (NYSE:ABBV) was one of the livelier stocks in Monday’s trading session. It was also one of the better-performing equities, gaining more than 6% that day. Much of this was due to a splashy new
Should You Buy Moderna Before Aug. 5?
Moderna (NASDAQ: MRNA) stock skyrocketed in early pandemic days -- and the company became a household name -- as it launched its coronavirus vaccine. This first product, and one using the new
Great News for Cheniere Energy and LNG Investors
While liquefied natural gas (LNG) stocks, such as Cheniere Energy (NYSE: LNG), have been traded as a proxy for negotiations over the immediate reopening of the Strait of Hormuz, the reality is that
Crypto Market Today, June 22: Bitcoin Holds Above $64,000 on Easing Geopolitical Tensions
As of early evening on June 22, Bitcoin (CRYPTO:BTC) rose 1.1% to $64,352.14, Ethereum (CRYPTO:ETH) rose 1.5% to $64,352.14, and Solana (CRYPTO:SOL) slipped 0.4% to $72.75.
Risk sentiment continues
10 Words From Apple CEO Tim Cook That Are Music to the Ears of Micron Technology Investors
Micron Technology (NASDAQ: MU) stock has been red hot over the past year amid an ongoing shortage of memory products driven by significant investments in artificial intelligence (AI). Micron's
Stock Market Today, June 22: Apogee Therapeutics Soars on AbbVie Cash Buyout Offer
Apogee Therapeutics (NASDAQ:APGE), a clinical-stage biologics company for inflammatory and immunology disorders, closed at $132.55, up 46.66%. AbbVie’s proposed $135.11-per-share cash acquisition
Bio-Rad vs. Charles River Labs: Which Medical Research Stock Is a Better Buy in 2026?
Is your portfolio better served by a diagnostic equipment leader or a pharmaceutical research titan? Deciding between Bio-Rad Laboratories (NYSE:BIO) and Charles River Laboratories International (NY
Stock Market Today, June 22: UiPath Falls as Agentic Automation Push Faces ARR Growth Test
UiPath (NYSE:PATH), an enterprise automation software provider, closed at $10.15, down 1.07%. UiPath traded lower despite the recent launch of Maestro Case, as investors continued to weigh its
Stock Market Today, June 22: Alphabet Falls as AlphaFold Co-Creator’s Exit Raises AI Talent Concerns
Alphabet (NASDAQ:GOOGL), a global search, ads, cloud, and AI platform, closed at $348.78, down 5.08%. Shares fell after reports that another AI leader left for a rival and amid legal and regulatory
Buying SpaceX Stock Isn't the Same as Buying Tesla's IPO Back in 2010. There's One Massive Difference
Space Exploration Technologies (NASDAQ: SPCX), also known as SpaceX, went public earlier this month amid some tremendous excitement. The rocket company, which is run by CEO Elon Musk, has a
Stock Market Today, June 22: Super Micro Computer Jumps After Introducing New Platform Accelerating AI Server Backlog Growth
Super Micro Computer (NASDAQ:SMCI), an AI-optimized server and storage systems provider, surged 15.66% to $35.46. Investors are watching AI server backlog growth and margin improvement with the
SpaceX Stock Is All Over the Place. 3 Dividend Stocks to Buy Instead That Will Let You Sleep Well at Night
Since going public on June 12, Space Exploration Technologies Corp. (NASDAQ: SPCX), better known as SpaceX, has experienced roller coaster price action. Going public at an initial public offering
Broadcom's AI Revenue Is on Pace to Triple to $16 Billion in a Single Quarter, but the Stock Just Dipped 17%. Is This an Opportunity to Buy the Dip?
Broadcom (NASDAQ: AVGO) shares recently sold off after the company reported a sharp acceleration in revenue growth. The stock has started to recover, but is still down 17% from its previous high at
Why CVS Stock Trounced the Market Today
CVS Health (NYSE: CVS) is pushing harder into a hot segment of the pharmacy market, and on Monday investors rewarded the company for the effort. The pharmacy retailer's stock rose 3% on the news


